Home / Cancer and immune system / Irinotecan
ATC L01CE02 · Antineoplastic Agents
Irinotecan shortage
As of 31 Oct 2026, Irinotecan has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 8 products.
Countries2/5
Products8packs or presentations
Short since3 Jul 20233.3 years ago
Earliest return1 Mar 2027company estimate
No return date4products
Main reasonManufacturing problem
Timeline
ItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | IRINOTECAN SUN ** | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 20 May 2025 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | IRINOTECAN ACCORD announced | ACCORD HEALTHCARE, S.L.U. | 27 Nov 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | CAMPTO announced | PFIZER ITALIA S.R.L. | 31 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | CAMPTO announced | PFIZER ITALIA S.R.L. | 29 Jan 2027 | not given | Manufacturing problem Problemi produttivi |
| BE | Irinotecan Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 15 ml | Eugia Pharma (Malta) | 3 Jul 2023 | 1 Mar 2027 | Other Other reason |
| BE | Irinotecan Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 2 ml | Eugia Pharma (Malta) | 3 Jul 2023 | 1 Mar 2027 | Other Other reason |
| BE | Irinotecan Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 25 ml | Eugia Pharma (Malta) | 3 Jul 2023 | 1 Mar 2027 | Other Other reason |
| BE | Irinotecan Eugia 20 mg/ml inf. sol. (conc.) i.v. vial 5 ml | Eugia Pharma (Malta) | 3 Jul 2023 | 1 Mar 2027 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.